| Assessing Risk Assessment in Action |
15 |
| What Makes Ensuring Access to Affordable Prescription Drugs the Hardest Problem in Health Policy? |
6 |
| The Legal Implications of the MeToo Movement |
6 |
| A Legal Theory of Shareholder Primacy |
6 |
| The Hidden Power of Compliance |
5 |
| Dangerous Times: The FDA's Role in Information Production, Past and Future |
4 |
| The Duty of Data Security |
4 |
| The Games They Will Play: Tax Games, Roadblocks, and Glitches Under the 2017 Tax Legislation |
4 |
| Too Big To Fool: Moral Hazard, Bailouts, and Corporate Responsibility |
3 |
| Too-Big-to-Fail Shareholders |
3 |
| Criminal Enforcement Redundancy: Oversight of Decisions Not to Prosecute |
3 |
| Inside Job: The Assault on the Structure of the Consumer Financial Protection Bureau |
3 |
| The Too Big to Fail Problem |
3 |
| An Empirical Examination of Agency Statutory Interpretation |
2 |
| Small Debts, Big Burdens |
2 |
| Congress's Agency Coordination |
2 |
| The Trouble with Counting: Cutting Through the Rhetoric of Red Tape Cutting |
2 |
| The Morality of Compulsory Licensing as an Access to Medicines Tool |
2 |
| Administrative Answers to Major Questions: On the Democratic Legitimacy of Agency Statutory Interpretation |
2 |
| Sanctuary Networks |
2 |
| Environmental Standards, Thresholds, and the Next Battleground of Climate Change Regulations |
2 |
| Carbon Taxation by Regulation |
2 |
| Strengthening Cybersecurity with Cyberinsurance Markets and Better Risk Assessment |
2 |
| When Database Queries Are Fourth Amendment Searches |
2 |
| The Production Function of the Regulatory State: How Much Do Agency Budgets Matter? |
2 |
| Shining a Light on the Shadow-of-Trial Model: A Bridge Between Discounting and Plea Bargaining |
2 |
| The Pregnancy Penalty |
2 |
| Coerced into Health: Workplace Wellness Programs and Their Threat to Genetic Privacy |
2 |
| Institutional Fracture in Intellectual Property Law: The Supreme Court Versus Congress |
1 |
| Inclusive Communities and Robust Causality: The Constant Struggle to Balance Access to the Courts with Protection for Defendants |
1 |
| The Foreign Emoluments Clause and the Chief Executive |
1 |
| Taobao, Federalism, and the Emergence of Law, Chinese Style |
1 |
| Positive and Negative Externalities in Real Estate Development |
1 |
| Globalization Without a Safety Net: The Challenge of Protecting Cross-Border Funding of NGOs |
1 |
| Admissions of Guilt in Civil Enforcement |
1 |
| Standing Voting Instructions: Empowering the Excluded Retail Investor |
1 |
| Regime Congruence: Rethinking the Scope of State Responsibility for Transboundary Environmental Harm |
1 |
| Campaigns, Inc |
1 |
| Behavioral Claim Construction |
1 |
| The Most Integrated Setting: Olmstead, Fry, and Segregated Public Schools for Students with Disabilities |
1 |
| Reconsidering Home Rule and City-State Preemption in Abandoned Fields of Law |
1 |
| Corporate Charter Competition |
1 |
| When Should Employers Be Liable for Factoring Biased Customer Feedback into Employment Decisions? |
1 |
| Graffiti, Speech, and Crime |
1 |
| Venerunt, Viderunt, Vicerunt Venue: How TC Heartland and In re Cray Have Conquered Patent Venue for Corporate Defendants and How Congress Can Balance the Scales of Patent Venue Justice |
1 |
| Religious Exemptions and LGBTQ Child Welfare |
1 |
| Delinking Reimbursement |
1 |
| Drug Approval in a Learning Health System |
1 |
| Regulatory Silence at the FDA |
0 |
| When Added Hurdles Cause Actual Prejudice: Exempting Knowing-Use-of-Perjured-Testimony Claims from Brecht Analysis on Collateral Review |
0 |
